Title : Risk of clinical deterioration in patients with lupus nephritis receiving rituximab.

Pub. Date : 2016 Oct

PMID : 27084027






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rituximab is a chimeric anti-CD20 monoclonal antibody that is used as an immunosuppressive agent in cyclophosphamide refractory lupus nephritis to induce remission. Cyclophosphamide keratin 20 Homo sapiens